disopyramide has been researched along with Angina Pectoris in 5 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thus disopyramide, probably because of its negative inotropic action, is useful in the management of patients with HCM when LV outflow obstruction is the main cause of the clinical-hemodynamic findings." | 1.27 | [Beneficial effects of disopyramide on left ventricular outflow obstruction in a case of hypertrophic obstructive cardiomyopathy]. ( Contini, GM; Dore, L; Franceschino, V; Ibba, GV; Terrosu, P, 1984) |
| "After treatment of ischemia and/or failure, specific antiarrhythmic agents, conventional and investigational, alone or in combination, are systematically selected." | 1.26 | Ventricular ectopy: etiology, evaluation, and therapy. ( Reid, PR; Vlay, SC, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasquale, F | 1 |
| Tomé-Esteban, MT | 1 |
| Morgagni, R | 1 |
| Elliott, P | 1 |
| Vlay, SC | 1 |
| Reid, PR | 1 |
| Terrosu, P | 1 |
| Franceschino, V | 1 |
| Contini, GM | 1 |
| Dore, L | 1 |
| Ibba, GV | 1 |
| Ruffy, R | 1 |
| Zipes, DP | 1 |
| Kirichenko, LL | 1 |
| Masenko, VP | 1 |
| Gorshkov, VA | 1 |
| Narynski, AK | 1 |
| Kurakina, TI | 1 |
| Morozova, LM | 1 |
| Mamaev, VI | 1 |
5 other studies available for disopyramide and Angina Pectoris
| Article | Year |
|---|---|
Provokable left ventricular outflow tract obstruction in a patient without hypertrophy.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Cardiac Pacing, Artificial; Diagnostic Imaging; D | 2009 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhyth | 1982 |
[Beneficial effects of disopyramide on left ventricular outflow obstruction in a case of hypertrophic obstructive cardiomyopathy].
Topics: Angina Pectoris; Cardiomyopathy, Hypertrophic; Disopyramide; Female; Humans; Middle Aged | 1984 |
Preventing ventricular arrhythmias in ischemic heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Lidocaine; Nitroglyce | 1979 |
Platelet aggregation and prostaglandin metabolites in the blood of patients with ischaemic heart disease during antiarrhythmic treatment.
Topics: Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Coronary Disease; Disopyramide; Female; Humans | 1989 |